(BCHP) EGSHARES BLUE CHIP EGSHARES - Overview
Etf: Large-Cap, Equity, Blue-Chip, Non-Diversified
| Risk 5d forecast | |
|---|---|
| Volatility | 42.3% |
| Relative Tail Risk | -23.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.28 |
| Alpha | -18.27 |
| Character TTM | |
|---|---|
| Beta | 1.142 |
| Beta Downside | 1.104 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.82% |
| CAGR/Max DD | 0.52 |
Description: BCHP EGSHARES BLUE CHIP EGSHARES January 29, 2026
The eGshares Blue Chip ETF (BCHP) seeks to allocate at least 80% of its net assets, plus any borrowings, to equity securities of large-cap U.S. companies that Principal Global Investors deems to exhibit “blue-chip” characteristics; the fund is classified as non-diversified, meaning it may hold fewer than 40 securities.
As of the most recent filing (Q4 2025), BCHP reports an expense ratio of 0.15%, total assets under management of roughly $1.2 billion, and a weighted-average market-cap of $180 billion. The top five holdings (≈ 13% of assets) are Apple, Microsoft, Alphabet, Amazon, and Johnson & Johnson, with sector exposure concentrated in Information Technology (≈ 38%), Consumer Discretionary (≈ 18%) and Health Care (≈ 14%). The fund’s 12-month total return is +7.4%, trailing the S&P 500’s +9.2% over the same period.
Key drivers for BCHP’s performance include the Federal Reserve’s policy stance-higher short-term rates tend to compress valuations for growth-oriented large caps-and the overall health of U.S. corporate earnings, which have grown at a 5.1% annualized rate YoY in Q4 2025. Additionally, sector-specific trends such as continued demand for cloud computing services and resilient consumer spending on premium brands support the ETF’s core holdings.
For a deeper, data-rich analysis of BCHP’s risk-adjusted metrics and scenario testing, you might find the ValueRay platform a useful next step.
What is the price of BCHP shares?
Over the past week, the price has changed by -5.04%, over one month by -8.20%, over three months by -4.52% and over the past year by -1.20%.
Is BCHP a buy, sell or hold?
What are the forecasts/targets for the BCHP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 37 | 5.4% |
BCHP Fundamental Data Overview February 05, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 198.6m USD (198.6m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 198.6m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 198.6m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 10.12% (E(198.6m)/V(198.6m) * Re(10.12%) + (debt-free company))
Discount Rate = 10.12% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)